These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6254540)
1. The 5'-monophosphates of 5-propyl- and 5-ethyl-2'-deoxyuridine do not inhibit the replication of deoxythymidine kinase deficient (TK-) mutants of herpes simplex virus. De Clercq E; Kulikowski T; Shugar D Biochem Pharmacol; 1980 Oct; 29(20):2883-5. PubMed ID: 6254540 [No Abstract] [Full Text] [Related]
2. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Docherty JJ; Dobson AT; Trimble JJ; Jennings BA Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822 [TBL] [Abstract][Full Text] [Related]
3. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. Balzarini J; de Clercq E; Ayusawa D; Seno T FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708 [TBL] [Abstract][Full Text] [Related]
5. Selection of L cell sublines resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Shiraki K; Vonka V; De Clercq E; Rapp F Intervirology; 1991; 32(4):228-33. PubMed ID: 1650764 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells. Balzarini J; De Clercq E Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982 [No Abstract] [Full Text] [Related]
7. The cytostatic activity of 5-(1-azidovinyl)-2'-deoxyuridine (AzVDU) against herpes simplex virus thymidine kinase gene-transfected FM3A cells is due to inhibition of thymidylate synthase and enhanced by UV light (lambda = 254 nm) exposure. Balzarini J; Andrei G; Kumar R; Knaus EE; Wiebe LI; De Clercq E FEBS Lett; 1995 Oct; 373(1):41-4. PubMed ID: 7589430 [TBL] [Abstract][Full Text] [Related]
8. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches. de Clercq E Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935 [No Abstract] [Full Text] [Related]
9. Synergistic effects on ganglionic herpes simplex virus infections by mutations or drugs that inhibit the viral polymerase and thymidine kinase. Jacobson J; Kramer M; Rozenberg F; Hu A; Coen DM Virology; 1995 Jan; 206(1):263-8. PubMed ID: 7831780 [TBL] [Abstract][Full Text] [Related]
11. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate. Yokota T; Konno K; Shigeta S; De Clercq E Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888 [TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
13. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine. Holliday J; Williams MV Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. Béres J; Sági G; Bentrude WG; Balzarini J; De Clercq E; Otvös L J Med Chem; 1986 Jul; 29(7):1243-9. PubMed ID: 3027328 [TBL] [Abstract][Full Text] [Related]
17. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. Field HJ; Wildy P J Hyg (Lond); 1978 Oct; 81(2):267-77. PubMed ID: 212476 [TBL] [Abstract][Full Text] [Related]
18. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. Griffiths A; Coen DM J Virol; 2003 Feb; 77(3):2282-6. PubMed ID: 12525666 [TBL] [Abstract][Full Text] [Related]
19. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior. Cheng YC Biochim Biophys Acta; 1976 Dec; 452(2):370-81. PubMed ID: 188465 [TBL] [Abstract][Full Text] [Related]
20. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]